Evidence map›Paper›PMID 42610726›Full record

ArticleThe Medical journal of Australia2026

Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011-2023): A Retrospective Cohort Study.

Evangeline Samuel, Eldho Paul, Mike Lloyd, Sanuki Tissera, Craig Underhill, Sagun Parakh, Phillip Parente, Inger Olesen, Javier Torres, Katharine See and 11 more

Abstract read
In one paragraph

Article in The Medical journal of Australia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Evangeline SamuelSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Eldho PaulSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Mike LloydSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Sanuki TisseraSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Craig UnderhillBorder Medical Oncology Research Unit, Albury Wodonga Regional Cancer Centre, Albury, New South Wales, Australia.
Sagun ParakhOlivia Newton-John Cancer Wellness and Research Centre, Melbourne, Victoria, Australia.
Phillip ParenteDepartment of Medical Oncology, Eastern Health, Melbourne, Victoria, Australia.
Inger OlesenAndrew Love Cancer Centre, Barwon Health, Geelong, Victoria, Australia.
Javier TorresDepartment of Medical Oncology, Goulburn Valley Health, Shepparton, Victoria, Australia.
Katharine SeeDepartment of Respiratory Medicine, Northern Health, Melbourne, Victoria, Australia.
Gavin M WrightDepartment of Cardiothoracic Surgery, University of Melbourne, Melbourne, Victoria, Australia.
David LangtonDepartment of Thoracic Medicine, Peninsula Health, Melbourne, Victoria, Australia.
Thomas JohnDepartment of Medical Oncology, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.
Matthew ConronDepartment of Respiratory Medicine, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
James BartlettDepartment of Respiratory Medicine, Western Health, Melbourne, Victoria, Australia.
Nicola AtkinParkville Integrated Palliative Care Service, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Nikolajs ZepsSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Susan V HardenSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Wasek FaisalDepartment of Medical Oncology, Grampians Health, Ballarat, Victoria, Australia.
John R ZalcbergSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Rob G StirlingDepartment of Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0001-9877-5450

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPatients in regional and rural areas consistently experience poorer lung cancer survival rates compared with those in metropolitan centres, but the reasons remain unclear. This study examined survival differences in non-small cell lung cancer (NSCLC) across Victoria and identified key prognostic factors contributing to these differences.

designRetrospective cohort study. SETTING AND

participantsNSCLC patients diagnosed between 1 July 2011 and 22 May 2023 identified from the Victorian Lung Cancer Registry (VLCR).

main outcome measuresResidential address and treatment institution were classified using the Modified Monash Model (MMM): Modified Monash (MM) category 1 (MM1) as metropolitan, MM2 as regional and MM3-MM7 as rural/remote. Demographic, socio-economic and cancer-specific factors were analysed as potential predictors of all-cause mortality.

resultsAmong 13,548 patients, 4244 (31%) lived in regional or rural/remote areas. Compared with metropolitan patients, these groups had higher smoking prevalence (metropolitan, 2848/9304 [31%] vs. regional, 366/1083 [34%] vs. rural, 1148/3161 [37%]) and were more likely to be Australian-born (metropolitan, 4919/9304 [53%] vs. regional, 873/1083 [81%] vs. rural, 2603/3161 [82%]; p < 0.001). Comorbidity burden was similar across groups (median, 1; interquartile range, 0.0-1.0; p = 0.19). Socio-economic disadvantage was more marked in regional and rural patients (median Index of Relative Socio-Economic Advantage and Disadvantage [IRSAD] deciles: metropolitan, 8.0 vs. regional, 5.0 vs. rural, 3.0; p < 0.001), and average travel times to treatment were longer (metropolitan, 0.4 vs. regional, 1.9 vs. rural, 2.8 h, respectively). Patients treated at regional institutions had poorer survival (hazard ratio [HR], 1.27; 95% confidence interval [CI], 1.19-1.35; p < 0.001). This difference persisted after adjustment for age, stage, performance status, smoking and comorbidities (HR, 1.11; 95% CI, 1.04-1.18; p = 0.001).

conclusionsRegional, rural and remote patients with NSCLC face greater socio-economic disadvantage and travel burdens, and experience poorer survival even after accounting for clinical and demographic factors. These findings highlight enduring inequities in lung cancer care and emphasise the need for targeted interventions to strengthen access, treatment equity and outcomes for non-metropolitan populations.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsResidence CharacteristicsRural PopulationUrban PopulationAgedAged, 80 and overFemaleHumansMaleMiddle AgedRegistriesRetrospective StudiesSmokingSocioeconomic Disparities in HealthSurvival Ratecancerlung diseasesregistriesrural health servicessurvival analysis

Identifiers

PMID42610726
PMCPMC13484183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.